Global Brigatinib Tablet Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 134

Report ID: 224634

Brigatinib Tablet is a cancer medicine that is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) who have been treated before with a cancer medicine called crizotinib.

According to this study, over the next five years the Brigatinib Tablet market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Brigatinib Tablet business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Brigatinib Tablet market by product type, application, key manufacturers and key regions and countries.

This study considers the Brigatinib Tablet value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
30mg
50mg
180mg
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
ARIAD Pharmaceuticals
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Brigatinib Tablet consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Brigatinib Tablet market by identifying its various subsegments.
Focuses on the key global Brigatinib Tablet manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Brigatinib Tablet with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Brigatinib Tablet submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Brigatinib Tablet Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Brigatinib Tablet Consumption 2013-2023
2.1.2 Brigatinib Tablet Consumption CAGR by Region
2.2 Brigatinib Tablet Segment by Type
2.2.1 30mg
2.2.2 50mg
2.2.3 180mg
2.3 Brigatinib Tablet Consumption by Type
2.3.1 Global Brigatinib Tablet Consumption Market Share by Type (2013-2018)
2.3.2 Global Brigatinib Tablet Revenue and Market Share by Type (2013-2018)
2.3.3 Global Brigatinib Tablet Sale Price by Type (2013-2018)
2.4 Brigatinib Tablet Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Brigatinib Tablet Consumption by Application
2.5.1 Global Brigatinib Tablet Consumption Market Share by Application (2013-2018)
2.5.2 Global Brigatinib Tablet Value and Market Share by Application (2013-2018)
2.5.3 Global Brigatinib Tablet Sale Price by Application (2013-2018)

3 Global Brigatinib Tablet by Players
3.1 Global Brigatinib Tablet Sales Market Share by Players
3.1.1 Global Brigatinib Tablet Sales by Players (2016-2018)
3.1.2 Global Brigatinib Tablet Sales Market Share by Players (2016-2018)
3.2 Global Brigatinib Tablet Revenue Market Share by Players
3.2.1 Global Brigatinib Tablet Revenue by Players (2016-2018)
3.2.2 Global Brigatinib Tablet Revenue Market Share by Players (2016-2018)
3.3 Global Brigatinib Tablet Sale Price by Players
3.4 Global Brigatinib Tablet Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Brigatinib Tablet Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Brigatinib Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Brigatinib Tablet by Regions
4.1 Brigatinib Tablet by Regions
4.1.1 Global Brigatinib Tablet Consumption by Regions
4.1.2 Global Brigatinib Tablet Value by Regions
4.2 Americas Brigatinib Tablet Consumption Growth
4.3 APAC Brigatinib Tablet Consumption Growth
4.4 Europe Brigatinib Tablet Consumption Growth
4.5 Middle East & Africa Brigatinib Tablet Consumption Growth

5 Americas
5.1 Americas Brigatinib Tablet Consumption by Countries
5.1.1 Americas Brigatinib Tablet Consumption by Countries (2013-2018)
5.1.2 Americas Brigatinib Tablet Value by Countries (2013-2018)
5.2 Americas Brigatinib Tablet Consumption by Type
5.3 Americas Brigatinib Tablet Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Brigatinib Tablet Consumption by Countries
6.1.1 APAC Brigatinib Tablet Consumption by Countries (2013-2018)
6.1.2 APAC Brigatinib Tablet Value by Countries (2013-2018)
6.2 APAC Brigatinib Tablet Consumption by Type
6.3 APAC Brigatinib Tablet Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Brigatinib Tablet by Countries
7.1.1 Europe Brigatinib Tablet Consumption by Countries (2013-2018)
7.1.2 Europe Brigatinib Tablet Value by Countries (2013-2018)
7.2 Europe Brigatinib Tablet Consumption by Type
7.3 Europe Brigatinib Tablet Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Brigatinib Tablet by Countries
8.1.1 Middle East & Africa Brigatinib Tablet Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Brigatinib Tablet Value by Countries (2013-2018)
8.2 Middle East & Africa Brigatinib Tablet Consumption by Type
8.3 Middle East & Africa Brigatinib Tablet Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Brigatinib Tablet Distributors
10.3 Brigatinib Tablet Customer

11 Global Brigatinib Tablet Market Forecast
11.1 Global Brigatinib Tablet Consumption Forecast (2018-2023)
11.2 Global Brigatinib Tablet Forecast by Regions
11.2.1 Global Brigatinib Tablet Forecast by Regions (2018-2023)
11.2.2 Global Brigatinib Tablet Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Brigatinib Tablet Forecast by Type
11.8 Global Brigatinib Tablet Forecast by Application

12 Key Players Analysis
12.1 ARIAD Pharmaceuticals
12.1.1 Company Details
12.1.2 Brigatinib Tablet Product Offered
12.1.3 ARIAD Pharmaceuticals Brigatinib Tablet Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 ARIAD Pharmaceuticals News
...

13 Research Findings and Conclusion